Desmoglein 3 contributes to tumorigenicity of pancreatic ductal adenocarcinoma through activating Src–FAK signaling
Authors:
Open Access
- 4 May 2021
- journal article
- research article
- Published by Taylor & Francis in Animal Cells and Systems
- Vol. 25 (3) , 195-202
Abstract
Desmogleins (DSGs), with the ability to link adjacent cells, have been shown to participate in the development of malignancy. DSG3 was up-regulated in various cancers, including lung, head and neck, and esophagus squamous cell carcinoma, which contributed to the tumor progression. The role of DSG3 in pancreatic ductal adenocarcinoma (PDAC) still remains elusive. Here, the expression of DSG3 was found to be enhanced in pancreatic cancer cell lines in vitro. Functional assays showed that shRNA-mediated knockdown of DSG3 decreased cell viability of pancreatic cancer cells and retarded the cell proliferation, migration and invasion. However, pcDNA-mediated over-expression of DSG3 exhibited reversed effect on pancreatic cancer cell progression. In addition, the in vivo assay demonstrated that transfection of shDSG3 lentiviruses into pancreatic cancer cells repressed the tumorigenicity of PDAC after the cancer cells were transplanted into mice subcutaneously. Elevated DSG3 expression promoted the phosphorylation of Src (p-Src), focal adhesion kinase (p-FAK) and AKT (p-AKT) in vitro, while silence of DSG3 reduced the expression of p-Src, p-FAK and p-AKT both in vitro and in vivo. In conclusion, DSG3, as an oncogene, contributed to the tumorigenicity of PDAC through activating Src–FAK signaling.Keywords
Funding Information
- Natural Science Foundation of Xinjiang Uygur Autonomous Region (2014211C119)
This publication has 30 references indexed in Scilit:
- DSG3 Facilitates Cancer Cell Growth and Invasion through the DSG3-Plakoglobin-TCF/LEF-Myc/Cyclin D1/MMP Signaling PathwayPLOS ONE, 2013
- Non‐junctional human desmoglein 3 acts as an upstream regulator of Src in E‐cadherin adhesion, a pathway possibly involved in the pathogenesis of pemphigus vulgarisThe Journal of Pathology, 2012
- RNAi-mediated inhibition of the desmosomal cadherin (desmoglein 3) impairs epithelial cell proliferationCell Proliferation, 2011
- Desmosomes: new perpetrators in tumour suppressionNature Reviews Cancer, 2011
- Desmoglein 3, via an Interaction with E-cadherin, Is Associated with Activation of SrcPLOS ONE, 2010
- Desmosomes: adhesive strength and signalling in health and diseaseBiochemical Journal, 2010
- Src signaling in cancer invasionJournal of Cellular Physiology, 2010
- Desmoglein 3 is overexpressed in inverted papilloma and squamous cell carcinoma of sinonasal cavityThe Laryngoscope, 2009
- The DesmosomeCold Spring Harbor Perspectives in Biology, 2009
- Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancerBMC Cancer, 2008